Adaptimmune Therapeutics plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MATRIX CAPITAL MANAGEMENT COMPANY, LP | 11/14/2024 | 37.68 M | $35.81 B | -3.32% | 14.73% |
| ECOR1 CAPITAL, LLC | 11/14/2024 | 27.40 M | $26.04 M | 0.00% | 10.71% |
| NEA MANAGEMENT COMPANY, LLC | 11/14/2024 | 17.08 M | $16.23 M | 0.00% | 6.68% |
| BAILLIE GIFFORD & CO | 11/05/2024 | 16.78 M | $15.94 M | 10.74% | 6.56% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 11/13/2024 | 13.30 M | $12.64 M | 7.72% | 5.20% |
| PFM HEALTH SCIENCES, LP | 11/14/2024 | 10.00 M | $9.50 M | -4.94% | 3.91% |
| MPM ASSET MANAGEMENT LLC | 11/13/2024 | 5.56 M | $5.28 M | 0.00% | 2.17% |
| BIOIMPACT CAPITAL LLC | 11/13/2024 | 5.10 M | $4.84 M | 0.00% | 1.99% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 4.65 M | $4.42 M | 0.00% | 1.82% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 2.43 M | $2.31 M | 0.00% | 0.95% |
| FMR LLC | 11/13/2024 | 1.74 M | $1.65 M | 2.98% | 0.68% |
| MORGAN STANLEY | 11/14/2024 | 1.70 M | $1.61 M | 285.41% | 0.66% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.66 M | $1.57 M | -7.26% | 0.65% |
| JPMORGAN CHASE & CO | 11/08/2024 | 1.05 M | $993,674 | 0.80% | 0.41% |
| REDMILE GROUP, LLC | 11/14/2024 | 715,607 | $680,113 | 0.00% | 0.28% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 715,350 | $679,869 | -8.24% | 0.28% |
| MARSHALL WACE, LLP | 11/14/2024 | 522,608 | $496,479 | 260.72% | 0.20% |
| RATHBONES GROUP PLC | 11/13/2024 | 432,818 | $411,350 | 0.00% | 0.17% |
| STATE STREET CORP | 11/14/2024 | 396,792 | $377,111 | 1.51% | 0.16% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 341,064 | $324,147 | 0.00% | 0.13% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 283,626 | $269,558 | 100.00% | 0.11% |
| KEY CLIENT FIDUCIARY ADVISORS, LLC | 10/18/2024 | 255,359 | $242,693 | -3.27% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 189,472 | $180,074 | -21.75% | 0.07% |
| JANE STREET GROUP, LLC | 11/15/2024 | 174,157 | $165,519 | 130.44% | 0.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 139,801 | $132,866 | 18.57% | 0.05% |
| VIRTU FINANCIAL LLC | 11/20/2024 | 101,008 | $96,000 | 27.47% | 0.04% |
| GSA CAPITAL PARTNERS LLP | 11/05/2024 | 99,662 | $95,000 | 100.00% | 0.04% |
| LPL FINANCIAL LLC | 11/08/2024 | 88,856 | $84,449 | -55.32% | 0.03% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 84,410 | $80,223 | 423.67% | 0.03% |
| CAPTRUST FINANCIAL ADVISORS | 11/14/2024 | 83,041 | $78,922 | 0.00% | 0.03% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 66,821 | $63,507 | 4.95% | 0.03% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 57,201 | $54,364 | 100.00% | 0.02% |
| BARCLAYS PLC | 11/19/2024 | 50,061 | $48,000 | 0.00% | 0.02% |
| GROUP ONE TRADING, L.P. | 11/14/2024 | 48,370 | $45,971 | 42.11% | 0.02% |
| VONTOBEL HOLDING LTD. | 10/16/2024 | 43,000 | $40,867 | 230.77% | 0.02% |
| OPPENHEIMER & CO INC | 11/05/2024 | 36,275 | $34,476 | -7.69% | 0.01% |
| FULLCIRCLE WEALTH LLC | 10/29/2024 | 35,000 | $25,802 | 100.00% | 0.01% |
| INVESCO LTD. | 11/12/2024 | 34,809 | $33,082 | 0.19% | 0.01% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 32,700 | $31,065 | 179.49% | 0.01% |
| COLUMBIA ADVISORY PARTNERS LLC | 10/18/2024 | 31,420 | $29,862 | 11.87% | 0.01% |
| CSS LLC/IL | 11/14/2024 | 30,702 | $29,179 | 0.00% | 0.01% |
| DLK INVESTMENT MANAGEMENT, LLC | 10/09/2024 | 30,512 | $28,999 | 0.00% | 0.01% |
| SIMON QUICK ADVISORS, LLC | 10/15/2024 | 30,452 | $28,942 | 1.51% | 0.01% |
| JANNEY MONTGOMERY SCOTT LLC | 10/29/2024 | 30,000 | $29,000 | 0.00% | 0.01% |
| CITADEL ADVISORS LLC | 11/14/2024 | 28,100 | $26,706 | -57.93% | 0.01% |
| NEWMAN DIGNAN & SHEERAR, INC. | 11/12/2024 | 27,957 | $20,610 | 100.00% | 0.01% |
| STIFEL FINANCIAL CORP | 11/14/2024 | 27,619 | $26,247 | 0.00% | 0.01% |
| IFG ADVISORY, LLC | 10/30/2024 | 27,500 | $26,136 | 100.00% | 0.01% |
| PROSPERITY WEALTH MANAGEMENT, INC. | 11/14/2024 | 24,620 | $23,399 | -7.51% | 0.01% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 10/24/2024 | 23,000 | $22,000 | 0.00% | 0.01% |
Adaptimmune Therapeutics plcinstitutional Ownership - FAQ's
During the previous two years, 104 institutional investors and hedge funds held shares of Adaptimmune Therapeutics plc. The most heavily invested institutionals were:
Matrix Capital Management Company, LP: 37.68 M
EcoR1 Capital, LLC: 27.4 M
NEA Management Company, LLC: 17.08 M
BAILLIE GIFFORD & CO: 16.78 M
Long Focus Capital Management, LLC: 13.3 M
PFM Health Sciences, LP: 10 M
59.29% of Adaptimmune Therapeutics plc stock is owned by institutional investors.
Institutional investors have bought a total of 152.14 M shares in the last 24 months. This purchase volume represents approximately $88.24 M in transactions.